The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell-surface vimentin positive circulating tumor cells as a diagnostic and prognostic indicator in pediatric sarcoma patients.
 
Long Dao
No Relationships to Disclose
 
Dristhi Ragoonanan
No Relationships to Disclose
 
Jessica Foglesong
No Relationships to Disclose
 
Izhar Singh Batth
No Relationships to Disclose
 
Wafik Tharwat Zaky
No Relationships to Disclose
 
Jonathan Benjamin Gill
Consulting or Advisory Role - Acceleron Pharma (I); Acceleron Pharma (I); Celgene (I); Legend Biotech (I); MEI Pharma (I); MEI Pharma (I); Puma Biotechnology (I)
 
Diane D. Liu
No Relationships to Disclose
 
Aisha Albert
No Relationships to Disclose
 
Nancy Beatriz Gordon
No Relationships to Disclose
 
Winston W. Huh
No Relationships to Disclose
 
Douglas James Harrison
No Relationships to Disclose
 
Cynthia E. Herzog
Stock and Other Ownership Interests - Amgen; Merck
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Array BioPharma; Genentech; Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Eugenie Kleinerman
No Relationships to Disclose
 
Richard Greg Gorlick
Research Funding - Eisai (Inst)
 
Najat C. Daw
Consulting or Advisory Role - Bayer; Incyte
 
Shulin Li
No Relationships to Disclose